Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi.
Mucinous colorectal cancers exhibit a characteristic set of molecular genetic alterations and may be derived from progenitor cells committed to the goblet cell lineage. Previously, we demonstrated that the MUC2 mucin gene promoter drives transgene reporter expression with high specificity in small intestinal goblet cells of transgenic mice. On the basis of these experiments, we reasoned that the MUC2 promoter could be used to drive SV40 T antigen (Tag) expression in the same cell type, decoupling them from their normal antiproliferative controls. A line of mice was established (MUCTag6) that expressed Tag in intestinal goblet cells as determined by RNA blot and immunohistochemical analysis. These goblet cells were markedly involuted however, most notably in the villi. Endogenous intestinal MUC2 message levels were reduced to about one third the normal level in these mice. However, absorptive cell lineage markers were comparable with nontransgenics. Bromodeoxyuridine-positive S-phase cells are limited to crypts in nontransgenic intestine but are present in both crypts and villi in MUCTag6. In contrast, mitotic cells were not present in the villi, indicating that MUCTag6 villi goblet cells do not progress into M phase. Apoptotic cells positive for terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling were increased more than fourfold in MUCTag6 villi (P < 0.0001), and apoptotic goblet cells were evident. Electron microscopic examination of MUCTag6 intestinal villi revealed the presence of degraded cell remnants containing mucin goblets together with other cell debris, further indicating apoptosis of the goblet cell lineage. Thus, the expression of Tag in intestinal goblet cells releases them from normal antiproliferative controls, causing their inappropriate entry into S phase even after they transverse the crypt/villus junction. They do not, however, progress to M phase. Instead, they undergo apoptosis with a high degree of efficiency in S or G(2) phase. These experiments demonstrate that apoptosis effectively blocks inappropriate goblet cell proliferation in the intestine, supporting its proposed role as an antineoplastic mechanism.
Gum
J R
JR
Department of Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, California 94121, USA. jgum@maelstrom.ucsf.edu
Hicks
J W
JW
Gillespie
A M
AM
Rius
J L
JL
Treseler
P A
PA
Kogan
S C
SC
Carlson
E J
EJ
Epstein
C J
CJ
Kim
Y S
YS
D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000096:biosynthesis* / Q000235:genetics; D017209:Apoptosis / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology*; D005260:Female; D020397:Goblet Cells / Q000166:cytology* / Q000276:immunology / Q000378:metabolism; D007421:Intestine, Small / Q000166:cytology* / Q000378:metabolism / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008871:Microvilli / Q000502:physiology; D055262:Mucin-2; D009077:Mucins / Q000235:genetics*; D009857:Oncogenes; D011401:Promoter Regions, Genetic; D016196:S Phase / Q000502:physiology
D000952:Antigens, Polyomavirus Transforming; C524626:Muc2 protein, mouse; D055262:Mucin-2; D009077:Mucins